JORDEN DAVID EMERSON

Executive buyer

Director, CEO/CFO · Nuo Therapeutics, Inc.

Every open-market stock purchase JORDEN DAVID EMERSON has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where how the prices paid compare to where the stock trades now.

Total bought

$9.5K

Open-market buys

Companies

Last buy

Aug 28, 2026

Where the buys stand today

AURX
Nuo Therapeutics, Inc.
2 purchases totalling $9.5K at an average of $1.09 per share. See all insider buying in AURX →
Avg price paid
$1.09
Latest price
—
Market cap
Unknown

All reported buys

Date	Ticker	Shares	Price	Value	Filing
Aug 28, 2026	AURX	7,984	$1.09	$8.7K	SEC ↗
Aug 27, 2026	AURX	789	$1.07	$844.2	SEC ↗

Follow new qualifying clusters involving JORDEN DAVID EMERSON or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

Start a trial See pricing

About this data

Figures are parsed from JORDEN DAVID EMERSON's Form 4 filings on SEC EDGAR (CIK 1313516) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.